event

Innovations in Radiopharmaceuticals: a Translational Oncology Symposium

17 September 2024 Find out more

Champions’ Translational Oncology Symposium

MDC Lead Scientist Benedetta Arno will be speaking at the ‘Innovations in Radiopharmaceuticals’ Symposium on 17 September.

Benedetta’s talk is ‘Translational Research in Radiopharmaceutical Development: An Industry Perspective in Navigating the Frontiers of Therapeutic Innovation’.

This Translational Oncology Symposium is focused entirely on radiopharmaceutical research and development. This symposium will spotlight the latest advancements in radioligand therapy, bringing together top experts, researchers, and innovators in advancing cancer treatment and accelerating new therapies.

Meeting Objectives:

  • Advancement in Oncology: Learn from industry experts how radiopharmaceuticals represent a major breakthrough in cancer treatment by combining a cancer-targeting agent with a radioactive isotope, offering advantages over traditional therapies.
  • Scientific Focus: The meeting is aimed to address challenges in radiopharmaceutical cancer therapy and promote significant advancements in cancer science through scientific collaborations.
  • Industry Engagement and Networking: The field is expanding with increasing involvement from major pharmaceutical companies and the meeting is aimed to foster formal and informal interactions among leading experts from biopharma companies.

Let others know you’re joining